DUBLIN–(BUSINESS WIRE)–The “Viscosupplementation: Global Market Overview” report has been added to ResearchAndMarkets.com’s offering.
This report offers a detailed picture of the viscosupplementation market. Viscosupplementation is indicated for the treatment of knee, hip, shoulder and ankle osteoarthritis. Hyaluronic acid viscosupplement is injected into joints to reduce joint pains and treat osteoarthritis.
It highlights the current and future market potential for viscosupplementation and provides a detailed analysis of the competitive environment, regulatory scenario, patent analysis, pipeline analysis, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as market shares for key market players.
This report details market shares for viscosupplementation based on procedure type, application and geography. Based on procedure type, the market is segmented into Three-Injection cycle, Single-Injection cycle and Five-Injection cycle procedure segments. Based on the application, the market is segmented into knee osteoarthritis, hip osteoarthritis, and the others segment.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the UK, France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for the year 2018 as the base year, with forecasts for 2019 Through 2025. Estimated values are based on viscosupplement manufacturers total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
The Report Includes:
- An overview of global viscosupplementation market
- Detailed market share of viscosupplementation based on product type, procedure type, injection cycle, and application
- Highlights of current and future market potential of viscosupplementation and a detailed analysis of the competitive environment, regulatory scenario, patent analysis, and drivers, challenges, and trends in market growth
- Knowledge about hyaluronic acid, a lubricating agent and discussion on how it enables smooth movement of bones
- Coverage of minimally invasive viscosupplementation procedures, new product innovations, and rapid product advancements
- Insights into strategic initiatives by major companies including partnerships, agreements, geographic expansions, R&D of products, new product launches, mergers and acquisitions and opportunities for the companies
- Company profiles of major global corporations within this market, including Anika Therapeutics Inc., Bioventus, Chugai Pharmaceuticals Co., Ltd., Sanofi and Seikagaku Corp.
Growth of the global market is attributed to the growing prevalence of knee osteoarthritis, a strong product pipeline for single and Three-Injection cycle market segments and strong investment into research and development activities by key market players, including Seikagaku Corp., Anika Therapeutics Inc., Bioventus, Fidia Farmaceutici, and others.
Increasing patient preference for new, minimally-invasive viscosupplementation procedures comes with a substantial increase in the prevalence of knee osteoarthritis in the U.S.
The U.S. is one of the major markets for viscosupplements. According to the U.S. Arthritis Foundation, osteoarthritis is the most common type of arthritis. It affects nearly 30 million people in the U.S. The increased number of osteoarthritis patients is likely to drive the market for viscosupplementation during the forecast period.
The global viscosupplementation market is segmented in this report by procedure type, application, and region.
Key Topics Covered:
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst’s Credentials
- Custom Research
- Related Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
- Osteoarthritis
- Etiology
- Epidemiology and Market Burden
- Prevalence of Osteoarthritis
- Disease Symptoms
- Risk Factors
- Diagnosis
- Treatments
- Reducing the Risk of Osteoarthritis
Chapter 4 Market Dynamics
- Market Drivers
- Increasing Prevalence of Knee Osteoarthritis
- Growing Elderly Population
- Emerging Countries
- Minimally Invasive Procedures
- Market Restraints
- Substitute Treatment Options
- Intellectual Property
- Insurance Denials
- Government Regulations
- Market Opportunities
- Patient Preference
- Strategic Initiatives
- New Product Launches and R&D
Chapter 5 Market Breakdown by Procedure Type
- Global Market for Viscosupplementation by Procedure Type
- Three-Injection Cycle
- Market Size and Forecast
- Single-Injection Cycle
- Market Size and Forecast
- Five-Injection Cycle
- Market Size and Forecast
Chapter 6 Market Breakdown by Application
- Global Market for Viscosupplementation by Application
- Knee Osteoarthritis
- Market Size and Forecast
- Hip Osteoarthritis
- Market Size and Forecast
- Other Applications (Shoulder and Ankle Osteoarthritis)
- Market Size and Forecast
Chapter 7 Market Breakdown by Region
- Global Market for Viscosupplementation by Region
- North America
- United States
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Market Size and Forecast
- Market Analysis
- Middle East and Africa
- Market Size and Forecast
- Market Analysis
Chapter 8 Regulatory Structure: Medical Devices
- Regulatory Background
- Regulation of Medical Devices by Country/Region
- U.S.
- European Union (EU)
- Japan
Chapter 9 Competitive Landscape
- Global Company Market Share Analysis
- Mergers and Acquisitions
- Agreements, Contracts, Collaborations and Partnerships
- New Product Launches
Chapter 10 Company Profiles
- Major Viscosupplement Manufacturers
- Anika Therapeutics Inc.
- Bioventus
- Chugai Pharmaceutical Co., Ltd.
- Ferring B.V.
- Fidia Farmaceutici S.P.A.
- Sanofi
- Seikagaku Corp.
- Other Prominent Companies
Chapter 11 Appendix: Acronyms
For more information about this report visit https://www.researchandmarkets.com/r/nw47pl
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900